A realist synthesis of quality improvement curricula in undergraduate and postgraduate medical education: what works, for whom, and in what contexts? A Brown, K Lafreniere, D Freedman, A Nidumolu, M Mancuso, K Hecker, ... BMJ Quality & Safety 30 (4), 337-352, 2021 | 43 | 2021 |
A narrative review of exercise and obsessive-compulsive disorder DE Freedman, MA Richter General Hospital Psychiatry 71 (July–August 2021), 1-10, 2021 | 23 | 2021 |
Neuropsychiatric Status of Patients With Multiple Sclerosis Across Disease Duration Intervals DE Freedman, J Oh, A Feinstein The Journal of Neuropsychiatry and Clinical Neurosciences 35 (3), 250-255, 2023 | 10 | 2023 |
The influence of depression and anxiety on cognition in people with multiple sclerosis: a cross-sectional analysis DE Freedman, J Oh, A Kiss, J Puopolo, M Wishart, C Meza, A Feinstein Journal of Neurology 271, 4885–4896, 2024 | 7 | 2024 |
Measurement-based care educational programmes for clinical trainees in mental healthcare: a scoping review protocol DE Freedman, AE Waddell, H Lam, A Bourdon, K Wang BMJ Open 11, e054751, 2021 | 3 | 2021 |
From Theory to Practice: Development and Evaluation of a Quality Improvement Curriculum for Psychiatry Residents A Nidumolu, D Freedman, M Bosma Journal of medical education and curricular development 11 (eCollection 2024 …, 2024 | 2 | 2024 |
Educating Mental Health Trainees About Measurement-Based Care: A Scoping Review DE Freedman, AE Waddell, A Bourdon, H Lam, K Wang Academic Psychiatry 47, 187-195, 2023 | 2 | 2023 |
Intimate partner violence and multiple sclerosis DE Freedman, K Krysko, A Feinstein Multiple Sclerosis Journal 30 (3), 295-298, 2024 | 1 | 2024 |
Professional development through resident lunches DE Freedman Academic Psychiatry 47, 565-566, 2023 | 1 | 2023 |
Comment on “I’m virtually a psychiatrist: problems with telepsychiatry in training” DE Freedman, A Zaretsky Academic Psychiatry 45 (6), 778-779, 2021 | 1 | 2021 |
Predictors of Antidepressant Use Among People With Multiple Sclerosis DE Freedman, J Oh, A Feinstein The Journal of Neuropsychiatry and Clinical Neurosciences, 2025 | | 2025 |
Not for everyone: Factors influencing who receives psychotherapy in people with multiple sclerosis DE Freedman, J Oh, A Feinstein Multiple Sclerosis and Related Disorders 94, 106245, 2025 | | 2025 |
Clinical dimensions of people with co-occurring obsessive-compulsive and related disorders and multiple sclerosis: a scoping review protocol DE Freedman, KM Sawicka, J Oh, E Main, KA Campbell, A Feinstein BMJ Open 14 (5), e074929, 2024 | | 2024 |
The influence of comorbid depression and anxiety on cognition in people with multiple sclerosis D Freedman, J Oh, A Kiss, J Puopolo, M Wishart, C Meza, A Feinstein MULTIPLE SCLEROSIS JOURNAL 29, 206-206, 2023 | | 2023 |
P442 Associations Between Psychotropic Medications and the Neuropsychiatric Symptoms of Multiple Sclerosis: An Exploratory Analysis DE Freedman, J Oh, A Feinstein Multiple Sclerosis Journal 29 (2), Supplemental, 2023 | | 2023 |
P368 The Age-Dependent Relationships between Depression, Anxiety and Cognition DE Freedman, J Oh, A Feinstein Multiple Sclerosis Journal 29 (2), Supplemental, 2023 | | 2023 |
Exploring how best to teach quality improvement throughout the continuum of medical training: a realist review of peer-reviewed and grey literature AK Allison Brown, Kyle Lafreniere, David Freedman, Aditya Nidumolu, Matthew ... Canadian Medical Education Journal 11 (2), 2020 | | 2020 |
P. 037 Keeping track of time: emphasizing symptom onset-to-hospital time in stroke care DE Freedman, N Behih, A Elmeligi, D Sahlas Canadian Journal of Neurological Sciences 46 (s1), S23-S24, 2019 | | 2019 |
EFFECT OF TRAUMATIC STRESS ON DOPAMINE-RELATED GENE EXPRESSION: A PRELIMINARY STUDY D Freedman, M Densmore, Z Nemoda, R Lanius EUROPEAN NEUROPSYCHOPHARMACOLOGY 27, S159-S160, 2017 | | 2017 |